POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection (PORSCH)
Primary Purpose
Pancreatic Diseases, Pancreatic Neoplasms, Pancreatic Cancer
Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Best practice algorithm for postoperative care
Sponsored by
About this trial
This is an interventional treatment trial for Pancreatic Diseases focused on measuring Postoperative pancreatic fistula, Pancreatic resection
Eligibility Criteria
Inclusion Criteria for Clusters:
- All Dutch centers performing pancreatic surgery (i.e. performing at least 20 pancreatoduodenectomies a year)
Exclusion Criteria for Clusters:
- None
Inclusion Criteria for Patients:
- Patients underoging pancreatic resection for any indication
Exclusion Criteria for Patients:
- None (i.e. complete enumeration)
Sites / Locations
- Jeroen Bosch ZiekenhuisRecruiting
- Academic Medical CenterRecruiting
- Onze Lieve Vrouwen GasthuisRecruiting
- VUmcRecruiting
- Amphia ziekenhuisRecruiting
- Reinier de Graaf gasthuisRecruiting
- Catharina ziekenhuisRecruiting
- Medisch Spectrum TwenteRecruiting
- UMCGRecruiting
- TjongerschansRecruiting
- LUMCRecruiting
- Maastricht UMCRecruiting
- Radboud UMCRecruiting
- Erasmus MCRecruiting
- Maasstad ziekenhuisRecruiting
- RAKU (St. Antonius ziekenhuis & UMC Utrecht)Recruiting
- Isala kliniekenRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Best practice
Current practice
Arm Description
Postoperative care according to a best practice algorithm for postoperative care focussing on early detection and minimally invasive management of postoperative pancreatic fistula.
Postoperative care according to current usual practice.
Outcomes
Primary Outcome Measures
Composite primary endpoint
The primary endpoint of this trial is a composite of the most severe complications associated to postoperative pancreatic fistula. This endpoint will be considered positive if one of the following complications occurs within 90 days after pancreatic resection: late postpancreatectomy bleeding, new-onset organ failure and/or death
Secondary Outcome Measures
Postoperative mortality
Measured as rate of death at 90-day follow-up
New-onset organ failure
Measured as organ failure occuring any time within 90 days after resection, not present at time of index pancreatic resection.
Late postpancreatectomy bleeding
Defined in accordance to the International Study Group on Pancreatic Surgery (ISGPS) definition as bleeding occurring any time after 24 hours after pancreatic resection.
Postoperative morbidity
Including complications according to the Clavien-Dindo system and pancreatectomy specific complications according to the ISGPS definitions (e.g. postpancreatectomy bleeding, postoperative pancreatic fistula, postoperative bile leak, postoperative chyle leak and delayed gastric emptying).
Adjuvant chemotherapy
Measured as number of patients receiving adjuvant chemotherapy at 90-day follow-up
Success of implementation
Measured as number of patients in whom the algorithm was not followed and timing of abdominal CT scans in both strategies.
Cost-effectiveness
Calculated by comparing health effects and medical costs related to both strategies up to 90 days after pancreatic resection.
Full Information
NCT ID
NCT03400280
First Posted
December 21, 2017
Last Updated
June 13, 2019
Sponsor
St. Antonius Hospital
Collaborators
Dutch Cancer Society
1. Study Identification
Unique Protocol Identification Number
NCT03400280
Brief Title
POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection
Acronym
PORSCH
Official Title
POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection. a Nationwide Stepped-Wedge Cluster Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 8, 2018 (Actual)
Primary Completion Date
November 9, 2019 (Anticipated)
Study Completion Date
February 9, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
St. Antonius Hospital
Collaborators
Dutch Cancer Society
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
This Nationwide stepped-wedge cluster randomized trial is designed to evaluate if the implementation of a best practice algorithm for postoperative care results in a decrease in incidence of major complications and death after pancreatic resection as compared to current practice.
Detailed Description
Rationale
Pancreatic resection is a major abdominal operation with 50% chance of postoperative complications. A feared complication is severe pancreatic fistula, in which there is leakage of enzyme rich fluid into the abdominal cavity. Adequate complication management appears to be the most important factor in improving outcomes of patients undergoing pancreatic resection.
Objective
To investigate whether implementation of a best practice algorithm for postoperative care focusing on early detection and step-up management of postoperative pancreatic fistula results in a lower rate of major complications and death after pancreatic resection as compared to current practice
Study design
A nationwide stepped-wedge, cluster randomized, superiority trial. In this design all participating centers cross over from current practice to best practice according to the algorithm, but are randomized to determine the exact order. At the end of the trial, all centers will have implemented the best practice algorithm.
Study population
All centers performing pancreatic surgery in the Netherlands (i.e. the Dutch Pancreatic Cancer Group).
Intervention
Cluster level education on postoperative care according to a best practice algorithm, focusing on early detection and step-up management of postoperative pancreatic fistula. This algorithm is based on findings in Dutch observational cohort studies, systematic literature analyses, an inventory in current protocols on postoperative care and expert opinion. The proposed algorithm is validated in a multicenter cohort and consensus upon this algorithm is reached with pancreatic surgeons from all centers of the Dutch Pancreatic Cancer Group. The final algorithm was reviewed critically by the advisory committee of internationally respected experts in the field of pancreatology before implementation in this trial.
Comparison
Postoperative care according to current practice.
Endpoints
The primary outcome was measured in all patients undergoing pancreatic resection and is a composite of major complications (i.e. postpancreatectomy bleeding, new-onset organ failure and death). Secondary endpoints include the individual components of the primary endpoint and other clinical outcomes, number of patients receiving adjuvant chemotherapy, healthcare resource utilization and costs analysis. Follow-up will be 90 days after pancreatic resection.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatic Diseases, Pancreatic Neoplasms, Pancreatic Cancer, Pancreatitis
Keywords
Postoperative pancreatic fistula, Pancreatic resection
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Stepped-wedge cluster randomized trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1600 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Best practice
Arm Type
Experimental
Arm Description
Postoperative care according to a best practice algorithm for postoperative care focussing on early detection and minimally invasive management of postoperative pancreatic fistula.
Arm Title
Current practice
Arm Type
No Intervention
Arm Description
Postoperative care according to current usual practice.
Intervention Type
Other
Intervention Name(s)
Best practice algorithm for postoperative care
Intervention Description
See arm/group description
Primary Outcome Measure Information:
Title
Composite primary endpoint
Description
The primary endpoint of this trial is a composite of the most severe complications associated to postoperative pancreatic fistula. This endpoint will be considered positive if one of the following complications occurs within 90 days after pancreatic resection: late postpancreatectomy bleeding, new-onset organ failure and/or death
Time Frame
90 days after index pancreatic resection
Secondary Outcome Measure Information:
Title
Postoperative mortality
Description
Measured as rate of death at 90-day follow-up
Time Frame
90 days after index pancreatic resection
Title
New-onset organ failure
Description
Measured as organ failure occuring any time within 90 days after resection, not present at time of index pancreatic resection.
Time Frame
90 days after index pancreatic resection
Title
Late postpancreatectomy bleeding
Description
Defined in accordance to the International Study Group on Pancreatic Surgery (ISGPS) definition as bleeding occurring any time after 24 hours after pancreatic resection.
Time Frame
90 days after index pancreatic resection
Title
Postoperative morbidity
Description
Including complications according to the Clavien-Dindo system and pancreatectomy specific complications according to the ISGPS definitions (e.g. postpancreatectomy bleeding, postoperative pancreatic fistula, postoperative bile leak, postoperative chyle leak and delayed gastric emptying).
Time Frame
90 days after index pancreatic resection
Title
Adjuvant chemotherapy
Description
Measured as number of patients receiving adjuvant chemotherapy at 90-day follow-up
Time Frame
90 days after index pancreatic resection
Title
Success of implementation
Description
Measured as number of patients in whom the algorithm was not followed and timing of abdominal CT scans in both strategies.
Time Frame
90 days after index pancreatic resection
Title
Cost-effectiveness
Description
Calculated by comparing health effects and medical costs related to both strategies up to 90 days after pancreatic resection.
Time Frame
90 days after index pancreatic resection
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria for Clusters:
All Dutch centers performing pancreatic surgery (i.e. performing at least 20 pancreatoduodenectomies a year)
Exclusion Criteria for Clusters:
None
Inclusion Criteria for Patients:
Patients underoging pancreatic resection for any indication
Exclusion Criteria for Patients:
None (i.e. complete enumeration)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jasmijn Smits, MD
Phone
+31887571207
Email
porsch@dpcg.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Hjalmar C van Santvoort, MD, PhD
Phone
+31887556489
Email
h.vansantvoort@umcutrecht.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Quintus Molenaar, MD, PhD
Organizational Affiliation
UMC Utrecht
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Hjalmar C van Santvoort, MD, PhD
Organizational Affiliation
St. Antonius Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Jeroen Bosch Ziekenhuis
City
's Hertogenbosch
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Koop Bosscha
Facility Name
Academic Medical Center
City
Amsterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marc Besselink
Facility Name
Onze Lieve Vrouwen Gasthuis
City
Amsterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sebastiaan Festen
Facility Name
VUmc
City
Amsterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Geert Kazemier
Facility Name
Amphia ziekenhuis
City
Breda
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer Schreinemakers
Facility Name
Reinier de Graaf gasthuis
City
Delft
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daphne Roos
Facility Name
Catharina ziekenhuis
City
Eindhoven
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ignace de Hingh
Facility Name
Medisch Spectrum Twente
City
Enschede
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mike Liem
Facility Name
UMCG
City
Groningen
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vincent de Meijer
Facility Name
Tjongerschans
City
Heerenveen
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fennie Wit
Facility Name
LUMC
City
Leiden
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bert Bonsing
Facility Name
Maastricht UMC
City
Maastricht
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ronald van Dam
Facility Name
Radboud UMC
City
Nijmegen
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marion van der Kolk
Facility Name
Erasmus MC
City
Rotterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Casper van Eijck
Facility Name
Maasstad ziekenhuis
City
Rotterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Erwin van der Harst
Facility Name
RAKU (St. Antonius ziekenhuis & UMC Utrecht)
City
Utrecht
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hjalmar van Santvoort
First Name & Middle Initial & Last Name & Degree
Quintus Molenaar
Facility Name
Isala klinieken
City
Zwolle
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gijs Patijn
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The datasets generated during and/or analysed during the current study are/will be available upon request from Hjalmar van Santvoort (h.van.santvoort@antoniusziekenhuis.nl)
IPD Sharing Time Frame
Upon request
IPD Sharing Access Criteria
Upon request
Citations:
PubMed Identifier
29941289
Citation
Smits FJ, Molenaar IQ, Besselink MG, Busch OR, van Eijck CH, van Santvoort HC; Dutch Pancreatic Cancer Group. Management of postoperative pancreatic fistula after pancreatoduodenectomy: high mortality after completion pancreatectomy: Reply to: Bressan et al. completion pancreatectomy in the acute management of pancreatic fistula after pancreaticoduodenectomy. HPB (Oxford). 2018 Dec;20(12):1223. doi: 10.1016/j.hpb.2018.05.015. Epub 2018 Jun 22. No abstract available.
Results Reference
derived
Learn more about this trial
POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection
We'll reach out to this number within 24 hrs